Newark, New Castle, USA, May 25, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global gene amplification technologies market was conducted by Growth Plus Reports in 2022 and is valued at US$ 1.70 billion. The market is expected to hit a revenue CAGR of 7.20% to reach US$ 3.18 billion by 2031.
Analysis of the global market for gene amplification technologies indicates that during the forecast period, revenue share is likely to increase significantly. Along with being crucial tools in many fields, such as genetics, biotechnology, forensic investigation, and medical diagnostics, gene amplification methods have changed the study of molecular biology.
Key Takeaways:
- The increasing adoption of personalized medicines is driving the market revenue share.
- The importance of gene amplification technology in drug discovery is driving the market demand.
- The emergence of new applications and demand for portable devices is increasing the market revenue growth rapidly.
Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/gene-amplification-technologies-market/8918
Gene Amplification Technologies Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 1.70 billion |
| Revenue Forecast in 2031 | US$ 3.18 billion |
| CAGR | 7.20% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Technology, Application, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Recent Development in the Gene Amplification Technologies Market:
- The isothermal amplification products Lyo-Ready Direct DNA LAMP saliva mix and Lyo-Ready Direct RNA/DNA LAMP saliva mix, which are primarily used in molecular diagnostics, was added to the Meridian Bioscience, Inc. product range in May 2022.
- Two new reverse transcription loop-mediated isothermal amplification-based products from Thermo Fisher Scientific were released in March 2022 and offered a quick and affordable technique to detect viral infections.
Competitive Landscape
A list of the companies operating in the global market for gene amplification technologies includes:
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- Abbott Laboratories
- Beckton, Dickinson, and Company
- PerkinElmer, Inc.
Market Drivers and Restraints:
The global gene amplification technologies market revenue is driven by technological advancements in molecular biology, particularly in DNA amplification. Furthermore, its applications in disease diagnosis, risk assessment, treatment selection, and monitoring of therapeutic response are contributing to the market revenue growth.
However, due to the high cost of these technologies limiting their accessibility in research laboratories and lack of skilled professionals, the gene amplification technologies market revenue growth is likely to be restrained.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/gene-amplification-technologies-market/8918
Market Segmentation:
- Based on technology, the global gene amplification technologies market is segmented into target amplification, loop-mediated isothermal amplification (lamp), nucleic acid sequence-based amplification, and others.
- Based on applications, the global gene amplification technologies market is segmented into medical and pharmaceutical, forensic and identity testing, and agriculture and food safety.
Segmentation By Technology
Based on the technology, the target amplification segment dominates the global gene amplification technologies market with the largest revenue share. This large revenue share is attributed to expanding use of polymerase chain reaction in areas like medical research, diagnostics, and drug development has led to an increase in demand for the technique. Furthermore, it is expected that the growing prevalence of genetic diseases will fuel the market's revenue expansion.
Regional Growth Dynamics
Based on the region, North America, with the largest revenue share, dominates the global gene amplification technologies market. This large revenue share is due to important firms in the area and the expanding use of gene amplification technologies for research and diagnostic purposes. Additionally, the proliferation of academic and scientific institutions in North America is promoting the use of gene amplification technology.
Report Coverage
Growth Plus Reports conducted extensive market research on the global gene amplification technologies market. We examined the fundamental market characteristics, significant investment opportunities, regional growth patterns, ten-year revenue estimates, competing market players, and mergers and acquisitions.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
- Target Amplification
- Loop-mediated Isothermal Amplification (LAMP)
- Nucleic Acid Sequence Based Amplification
- Others
- GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET - ANALYSIS & FORECAST, BY APPLICATION
- Medical and Pharmaceutical
- Forensic and Identity Testing
- Agriculture and Food Safety
GENE AMPLIFICATION TECHNOLOGIES MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8918
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Knee Arthrodesis Implants Market by Product Type (Standard Implants, Customized Implants), Technique (Long Intramedullary Nail, Short Intramedullary Nail), Implantation Technique (Cemented Implantation), End User (Hospitals & Clinics, Emergency Service Centers) – Global Outlook & Forecast 2023-2031
Oncology Imaging Software Market by Indication (Breast Cancer, Lung Cancer), Imaging Technique (CT Scan, MRI), Mode of Delivery (On-cloud, On-premise) – Global Outlook & Forecast 2023-2031
Acute Kidney Injuries Market by Type of Injuries (Pre-renal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injuries, Post-renal Acute Kidney Injuries), Treatment (Drug Therapy, Dialysis) - Global Outlook and Forecast 2023-2031
Mirvetuximab Soravtansine Market by Indication (Ovarian Cancer, Fallopian Tube Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Calcium Homeostasis Drugs Market by Drug Class (Calcium Metabolism Modifiers, Parathyroid Hormone Analogs), Indication (Hypocalcemia, Hypercalcemia), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031
Unleashing the Power of Innovation in Med Tech https://growthplusmedtechroundup.com/
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
